Big Move For Voyager Therapeutics, Inc.
Tue, May 09, 2023 at 07:39 PM
Voyager Therapeutics, Inc. (VYGR:NASDAQ) jumped higher at $10.76, representing a gain of 29.5%. On Tue, May 09, 2023, VYGR:NASDAQ hit a New 2-Week High of $10.76. The stock appeared on our News Catalysts scanner on Tue, May 09, 2023 at 07:46 AM in the 'INVESTOR UPDATE' category. From Tue, Apr 25, 2023, the stock recorded 50.00% Up Days and 63.64% Green Days
About Voyager Therapeutics, Inc. (VYGR:NASDAQ)
Voyager Therapeutics Inc, in collaboration with Genzyme, conducts research and development work to develop therapies for the treatment of central nervous system disorders. It targets diseases such as Parkinson's, Alzheimer's Huntington's.
Top 10 Gainers:
- Shengfeng Development Limited (SFWL:NASDAQ), 98.65%
- ClearOne, Inc. (CLRO:NASDAQ), 72.58%
- TScan Therapeutics Inc. (TCRX:NASDAQ), 58.14%
- Bright Health Group Inc. (BHG:NYSE), 52.94%
- Y-mAbs Therapeutics, Inc. (YMAB:NASDAQ), 36.34%
- Venus Concept Inc. (VERO:NASDAQ), 34.89%
- Uxin Limited (UXIN:NASDAQ), 32.79%
- Voyager Therapeutics, Inc. (VYGR:NASDAQ), 29.48%
- Latham Group Inc. (SWIM:NASDAQ), 29.3%
- MultiPlan Corporation Class A (MPLN:NYSE), 29.07%